Salarius Pharmaceuticals (SLRX) Short Interest Ratio & Short Volume $1.66 +0.17 (+11.64%) (As of 12/26/2024 05:45 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Salarius Pharmaceuticals Short Interest DataSalarius Pharmaceuticals (SLRX) has a short interest of 26,300 shares, representing 1.88% of the float (the number of shares available for trading by the public). This marks a -27.75% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 706,513 shares to cover all short positions.Current Short Interest26,300 sharesPrevious Short Interest36,400 sharesChange Vs. Previous Month-27.75%Dollar Volume Sold Short$38,658.37Short Interest Ratio0.1 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares1,441,000 sharesFloat Size1,400,000 sharesShort Percent of Float1.88%Today's Trading Volume94,123 sharesAverage Trading Volume706,513 sharesToday's Volume Vs. Average13% Short Selling Salarius Pharmaceuticals? Sign up to receive the latest short interest report for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSLRX Short Interest Over TimeSLRX Days to Cover Over TimeSLRX Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Salarius Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/202426,300 shares $38,658.37 -27.8%1.9%0.1 $1.47 11/30/202436,400 shares $52,052.00 -33.8%2.6%0.1 $1.43 11/15/202455,000 shares $73,700.00 -15.4%3.9%0.2 $1.34 10/31/202465,000 shares $104,650.00 +4,233.3%4.6%0.2 $1.61 10/15/20241,500 shares $2,280.00 -90.0%0.1%0 $1.52 9/30/202415,000 shares $21,600.00 +59.6%1.1%0 $1.44 Get the Latest News and Ratings for SLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/15/20249,400 shares $14,664.00 -38.6%0.7%0 $1.56 8/31/202415,300 shares $25,398.00 -64.0%1.1%0 $1.66 8/15/202442,500 shares $85,425.00 -50.8%3.2%0 $2.01 7/31/202486,300 shares $220,928.00 +44.1%15.4%0 $2.56 7/15/202459,900 shares $106,622.00 +215.3%10.7%0 $1.78 6/30/202419,000 shares $45,220.00 +375.0%27.1%0.9 $2.38 6/15/20244,000 shares $13,526.40 -85.4%5.7%0.2 $3.38 5/31/202427,300 shares $12,645.36 -18.5%0.6%0.2 $0.46 5/15/202433,500 shares $15,343.00 -54.5%0.8%0.3 $0.46 4/30/202473,600 shares $36,726.40 -36.3%1.7%0.6 $0.50 4/15/2024115,600 shares $57,800.00 -57.0%2.6%1 $0.50 3/31/2024268,900 shares $142,140.54 +1,767.4%6.7%2.4 $0.53 3/15/202414,400 shares $9,360.00 -20.0%0.4%0.1 $0.65 2/29/202418,000 shares $12,060.00 +227.3%0.5%0.6 $0.67 2/15/20245,500 shares $3,245.00 -33.7%0.2%0.2 $0.59 1/31/20248,300 shares $4,556.70 +36.1%0.2%0.2 $0.55 1/15/20246,100 shares $3,721.00 -37.1%0.2%0.2 $0.61 12/31/20239,700 shares $6,305.00 +38.6%0.3%0.3 $0.65 12/15/20237,000 shares $4,515.00 -71.9%0.2%0.1 $0.65 11/30/202324,900 shares $17,679.00 -56.0%0.7%0.4 $0.71 11/15/202356,600 shares $40,752.00 -22.7%1.6%1.1 $0.72 10/31/202373,200 shares $61,334.28 +136.9%2.3%1.2 $0.84 10/15/202330,900 shares $21,321.00 +62.6%0.9%0.5 $0.69 9/30/202319,000 shares $12,500.08 -6.4%0.6%0.3 $0.66 9/15/202320,300 shares $17,395.07 -26.5%0.6%0.4 $0.86 8/31/202327,600 shares $24,285.24 +162.9%0.8%0.5 $0.88 8/15/202310,500 shares $7,490.70 +54.4%0.3%0.2 $0.71 7/31/20236,800 shares $6,249.20 -60.9%0.2%0.1 $0.92 7/15/202317,400 shares $19,314.00 -44.8%0.6%0.2 $1.11 6/30/202331,500 shares $46,935.00 -41.2%1.0%0.3 $1.49 6/15/202353,600 shares $85,224.00 +9.6%1.7%0.5 $1.59 5/31/202348,900 shares $68,949.00 -48.4%2.1%0.5 $1.41 5/15/202394,700 shares $136,368.00 -16.1%4.2%1 $1.44 4/30/2023112,800 shares $200,784.00 -11.9%5.4%1.3 $1.78The Current Gold Supercycle Explained (Ad)If you haven’t been paying attention to gold… you’re missing out! Over the last year, it’s been on a tear… And the same guy who called this massive rally on December 7th 2023 also says we’re just getting warmed up! Inside, you’ll learn the “why” behind this massive rally and the key reasons Geof believes the gold supercycle is just beginning! Plus he’ll give you some insights on how to actively trade this generational opportunity. While we cannot promise future returns or protection against losses, these insights can help you make informed decisions. Read the eBook NowCheck out the free eBook he put together to explain it 4/15/2023128,000 shares $220,160.00 +6.1%6.1%2.5 $1.72 3/31/2023120,700 shares $230,537.00 -4.2%5.8%0.8 $1.91 3/15/2023126,000 shares $255,780.00 -4.0%6.6%0.7 $2.03 2/28/2023131,300 shares $279,669.00 +16.7%6.8%0.7 $2.13 2/15/2023112,500 shares $252,000.00 +11.3%5.9%0.6 $2.24 1/31/2023101,100 shares $260,838.00 +37.7%5.2%0.6 $2.58 1/15/202373,400 shares $194,510.00 +272.6%3.8%0.4 $2.65 12/30/202219,700 shares $30,141.00 -46.6%1.0%0.3 $1.53 12/15/202236,900 shares $55,719.00 +93.2%1.9%0.8 $1.51 11/30/202219,100 shares $36,863.00 -12.0%1.0%0.4 $1.93 11/15/202221,700 shares $46,655.00 +100.9%1.1%0.5 $2.15 10/31/202210,800 shares $21,924.00 -31.2%0.5%0.3 $2.03 10/15/202215,700 shares $71,042.50 -95.8%0.8%0.4 $4.53 9/30/2022371,000 shares $72,345.00 -8.4%N/A0.9 $0.20 9/15/2022405,000 shares $95,904.00 +9.6%N/A0.8 $0.24 8/31/2022369,500 shares $74,269.50 -16.3%N/A0.7 $0.20 8/15/2022441,600 shares $99,360.00 +257.3%N/A0.7 $0.23 7/31/2022123,600 shares $23,508.72 +7.3%N/A0.1 $0.19 7/15/2022115,200 shares $21,876.48 -33.8%N/A0.1 $0.19 6/30/2022174,100 shares $36,561.00 -54.6%N/A0.1 $0.21 6/15/2022383,300 shares $77,733.24 -9.8%N/A0.3 $0.20 5/31/2022425,000 shares $76,627.50 -3.8%N/A0.4 $0.18 5/15/2022441,800 shares $83,014.22 -26.6%N/A0.4 $0.19 4/30/2022602,200 shares $121,644.40 +31.4%N/A1.1 $0.20 4/15/2022458,300 shares $163,658.93 -14.7%N/A1.1 $0.36 3/31/2022537,100 shares $213,819.51 +11.7%N/A1.3 $0.40 3/15/2022480,900 shares $165,429.60 -23.8%N/A1 $0.34 2/28/2022630,900 shares $252,423.09 +0.4%N/A1.8 $0.40 2/15/2022628,200 shares $285,831.00 -3.7%N/A1.7 $0.46 1/31/2022652,400 shares $293,580.00 -2.0%4.5%1.5 $0.45 1/15/2022665,600 shares $312,832.00 +4.2%4.6%1.4 $0.47 12/31/2021638,500 shares $316,440.60 -7.3%4.4%1.3 $0.50 12/15/2021688,600 shares $365,853.18 -35.0%4.7%1.4 $0.53 11/30/20211,060,000 shares $689,000.00 +1.0%7.3%1.5 $0.65 11/15/20211,050,000 shares $796,950.00 +7.5%7.2%1.1 $0.76 10/29/2021976,600 shares $808,331.82 -0.2%6.7%0.8 $0.83 10/15/2021978,900 shares $886,002.39 -24.1%6.7%0.8 $0.91 9/30/20211,290,000 shares $1.32 million -4.4%8.9%1 $1.02 9/15/20211,350,000 shares $1.39 million -2.9%9.3%1 $1.03 8/31/20211,390,000 shares $1.45 million +9.5%9.6%1 $1.04 8/13/20211,270,000 shares $1.17 million -8.0%8.8%0.7 $0.92 7/30/20211,380,000 shares $1.12 million -9.2%9.5%0.8 $0.81 7/15/20211,520,000 shares $1.38 million -19.2%10.5%0.9 $0.91 6/30/20211,880,000 shares $1.99 million +0.5%13.0%1.1 $1.06 6/15/20211,870,000 shares $2.24 million +14.7%12.9%1.1 $1.20 5/28/20211,630,000 shares $2.09 million -2.4%11.3%1 $1.28 5/14/20211,670,000 shares $2.04 million +29.5%N/A1.3 $1.22 4/30/20211,290,000 shares $1.72 million -5.8%N/A0.6 $1.33 4/15/20211,370,000 shares $1.78 million -12.7%N/A0.6 $1.30 3/31/20211,570,000 shares $2.25 million +41.4%N/A0.6 $1.43The Current Gold Supercycle Explained (Ad)If you haven’t been paying attention to gold… you’re missing out! Over the last year, it’s been on a tear… And the same guy who called this massive rally on December 7th 2023 also says we’re just getting warmed up! Inside, you’ll learn the “why” behind this massive rally and the key reasons Geof believes the gold supercycle is just beginning! Plus he’ll give you some insights on how to actively trade this generational opportunity. While we cannot promise future returns or protection against losses, these insights can help you make informed decisions. Read the eBook NowCheck out the free eBook he put together to explain it 3/15/20211,110,000 shares $1.81 million -41.6%N/A0.4 $1.63 2/26/20211,900,000 shares $3.67 million +15.2%N/A0.7 $1.93 2/12/20211,650,000 shares $4.36 million +202.6%N/A0.6 $2.64 1/29/2021545,200 shares $594,268.00 -11.3%N/A0.3 $1.09 1/15/2021614,300 shares $712,588.00 +7.3%N/A0.6 $1.16 12/31/2020572,800 shares $510,937.60 +22.8%N/A0.7 $0.89 12/15/2020466,600 shares $407,295.14 -2.1%N/A0.8 $0.87 11/30/2020476,400 shares $325,857.60 -18.6%N/A1.1 $0.68 11/15/2020585,000 shares $427,050.00 +3.0%N/A3.9 $0.73 10/30/2020568,000 shares $382,434.40 -11.4%N/A3.6 $0.67 10/15/2020640,800 shares $583,128.00 -5.2%N/A2.8 $0.91 9/30/2020675,900 shares $570,392.01 +22.7%N/A2.9 $0.84 9/15/2020551,100 shares $506,736.45 -4.2%N/A2.2 $0.92 8/31/2020575,000 shares $540,500.00 +1.4%N/A1.6 $0.94 8/14/2020567,000 shares $569,835.00 -40.8%N/A1 $1.01 7/31/2020958,000 shares $1.10 million +3.7%N/A1.4 $1.15 7/15/2020924,200 shares $1.22 million -6.1%N/A1.3 $1.32 6/30/2020984,200 shares $1.30 million +0.6%N/A1.4 $1.32 6/15/2020978,400 shares $1.50 million +48.5%N/A1.4 $1.53 5/29/2020659,000 shares $691,950.00 +120.0%N/A1.1 $1.05 5/15/2020299,600 shares $254,689.96 +14.5%N/A0.7 $0.85 4/30/2020261,700 shares $217,237.17 +38.0%N/A0.6 $0.83 4/15/2020189,600 shares $117,589.92 +83.5%N/A0.6 $0.62 3/31/2020103,300 shares $65,079.00 +37.4%N/A0.4 $0.63 3/13/202075,200 shares $51,888.00 +89.4%N/A0.3 $0.69 2/28/202039,700 shares $24,614.00 +146.6%N/A0.1 $0.62 2/14/202016,100 shares $12,558.00 -89.4%0.5%0.1 $0.78 1/31/2020151,700 shares $131,979.00 +89.9%4.8%0.9 $0.87 1/15/202079,900 shares $67,116.00 -24.4%2.5%1.2 $0.84 12/31/2019105,700 shares $288,561.00 +101.7%3.7%1.8 $2.73 SLRX Short Interest - Frequently Asked Questions What is Salarius Pharmaceuticals' current short interest? Short interest is the volume of Salarius Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of December 15th, investors have sold 26,300 shares of SLRX short. 1.88% of Salarius Pharmaceuticals' shares are currently sold short. Learn More on Salarius Pharmaceuticals' current short interest. What is a good short interest percentage for Salarius Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.88% of Salarius Pharmaceuticals' floating shares are currently sold short. Is Salarius Pharmaceuticals' short interest increasing or decreasing? Salarius Pharmaceuticals saw a decrease in short interest in the month of December. As of December 15th, there was short interest totaling 26,300 shares, a decrease of 27.7% from the previous total of 36,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Salarius Pharmaceuticals' float size? Salarius Pharmaceuticals currently has issued a total of 1,441,000 shares. Some of Salarius Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Salarius Pharmaceuticals currently has a public float of 1,400,000 shares. How does Salarius Pharmaceuticals' short interest compare to its competitors? 1.88% of Salarius Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Salarius Pharmaceuticals: Indaptus Therapeutics, Inc. (1.00%), Aytu BioPharma, Inc. (2.14%), Cyclerion Therapeutics, Inc. (6.08%), Addex Therapeutics Ltd (1.06%), Orgenesis Inc. (0.29%), RedHill Biopharma Ltd. (0.42%), Mustang Bio, Inc. (0.81%), Biofrontera Inc. (8.54%), Genprex, Inc. (7.67%), Eagle Pharmaceuticals, Inc. (2.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Salarius Pharmaceuticals stock? Short selling SLRX is an investing strategy that aims to generate trading profit from Salarius Pharmaceuticals as its price is falling. SLRX shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Salarius Pharmaceuticals? A short squeeze for Salarius Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SLRX, which in turn drives the price of the stock up even further. How often is Salarius Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLRX, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies INDP Short Interest AYTU Short Interest CYCN Short Interest ADXN Short Interest ORGS Short Interest RDHL Short Interest MBIO Short Interest BFRI Short Interest GNPX Short Interest EGRX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLRX) was last updated on 12/27/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salarius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Salarius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
